Skip to content
Screener

Accounts Payable at other companies

Polaryx Therapeutics, Inc. logo
Polaryx Therapeutics, Inc.PLYX
$850K+5,100%
Veradermics logo
VeradermicsMANE
$1.07M+256%
GPA
General Purpose Acquisition Corp.GPAC
$8.46M-29.1%
Schering-Plough logo
Schering-PloughSGP
$3.51M+1,045%
Dollar General logo
Dollar GeneralDG
$4.34B+13.2%
Target logo
TargetTGT
$12.19B+3.1%

Other financials

Income statement

See full
Revenue$26.0M+98.9%
Gross profit$14.5M+126%
Operating income-$12.3M-44.4%
Net income-$21.3M-178%
EPS (diluted)-$1.74-156%

Balance sheet

See full
Cash & equivalents$64.6M
Total debt$30.6M
Total equity-$178.1M
Total assets$186.5M

Cash flow

See full
Operating cash flow-$20.3M-55.7%
CapEx$600.0K+8.3%
Free cash flow-$20.9M-53.8%

Valuation

See full
Market cap$1.96B+37.6%
Enterprise value$1.93B

Returns & leverage

See full
Debt / equity-0.2×
Current ratio5.9×

Where this comes from

Reported directly by Alamar Biosciences in its filing.

Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.

The source filing: Alamar Biosciences’s 10-Q, filed May 8, 2026. Open the filing →

Filed
May 8, 2026, 8:30 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-213424

FAQ

What is Alamar Biosciences's accounts payable?
Alamar Biosciences (ALMR) reported accounts payable of $5.64M in Q1 2026.
What does accounts payable mean?
Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.

Ask your AI about Alamar Biosciences's accounts payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude